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Abstract
The simulated data set of the Genetic Analysis Workshop 15 provided affection status, four
quantitative traits, and a covariate. After studying the relationship between these variables, linkage
analysis was undertaken. Analyses were performed in the first replicate only and without any prior
knowledge of the underlying model. In addition to the main effect of the DR locus on chromosome
6, significant linkage was also identified on chromosomes 8, 9, 11, and 18. Notably, the power to
detect linkage increased after transforming the skewed and kurtotic IgM and anti-CCP
distributions. Moreover, genes on chromosome 11 could not be discerned from noise without the
transformation, thus highlighting the need in real life situations for careful examination of the
phenotypic data prior to genetic analysis. Significant association with one single-nucleotide
polymorphism was identified for the regions on chromosome 11 and 18. Haplotype analyses were
attempted for the other regions, but only the underlying variation of the DR locus could be
identified. Two methods were then applied to predict classification using the factors identified so
far. These methods – logistic regression and multifactor dimensionality reduction (MDR) –
performed comparably for this data set. Those affected individuals that were misclassified as
unaffected were then used in a genome-wide association analysis to identify additional susceptibility
loci. Two additional loci were identified in this fashion, illustrating the usefulness of this two-stage
classification approach.
Background
Studies designed to identify genes contributing to com-
plex diseases have been ongoing for many years, utilizing
different study designs and methods with varied success.
The simulated data set of the Genetic Analysis Workshop
15 (GAW15) provided an opportunity to evaluate differ-
ent analysis techniques used to identify genes underlying
complex phenotypes. I have also attempted to predict dis-
ease status given the presence of apparent "high risk" alle-
les (those alleles associated with disease or
endophenotypes) identified in analyses, with the intent of
further studying those individuals that are misclassified.
Ideally, these individuals will be enriched for susceptibil-
ity genes not identified in the first round of analyses.
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Methods
All analyses were performed using the simulated data set
without knowledge of the underlying model, including
number of genes or their location. Analyses were per-
formed with complete genotypic and phenotypic data
from Replicate 1.
Phenotype
The simulated data set included a number of continuous
traits as well as affection status for the simulated disease.
The alleles at the main susceptibility locus (DR) were also
provided in the phenotype file, as was smoking history.
The relationships between these variables were inferred
using linear and logistic regression, and significant results
were included in subsequent analyses as covariates.
First-stage genetic analysis
A genome screen was performed for affection status using
the nonparametric linkage analysis methods imple-
mented in Mapmaker/SIBS [1]. Quantitative trait locus
(QTL) analysis was also performed for age at onset, sever-
ity, IgM, and anti-CCP using both Haseman-Elston regres-
sion [2] and the variance components method
implemented in SOLAR [3]. Those trait distributions with
unacceptable levels of kurtosis were adjusted using a nat-
ural log transformation before being analyzed.
Association analyses were performed for SNPs contained
within regions with a LOD score greater than 3.0, using
the pedigree disequilibrium test (PDT) [4]. Continuous
traits were analyzed with linear regression using additive
models.
The provided (phased) haplotypes were used in windows
increasing from one to six SNPs for each chromosomal
region to determine if haplotypes were more powerful
than individual SNPs at predicting any particular trait. R2
values were maximized in this way, with the understand-
ing that a parsimonious model was preferable given com-
parable R2 estimates.
Prediction of phenotype
Logistic regression and multifactor dimensionality reduc-
tion (MDR) [4] were used to quantify the effects of the
apparent high-risk alleles identified in these genetic anal-
yses. While the MDR software is designed to classify cases
and controls, logistic regression only provides a predicted
value between zero and one for each individual. There-
fore, a threshold for these predicted values was chosen by
maximizing sensitivity and specificity and was then used
to dichotomize the predicted values into cases and con-
trols. For both methods, the dependent variable was affec-
tion status, and the number of copies for each high-risk
allele was used as an independent variable. Smoking his-
tory and gender were also included where appropriate.
The first affected sibling from each family was used along
with an equal number of controls. The same approach
using linear regression was also used for the quantitative
traits.
Second-stage genetic analysis
Those affected individuals that were misclassified by the
MDR algorithm were used in a genome-wide association
study. PDT was used to ensure that trios from the same
family would not bias the test statistic.
Results
Phenotype
Affection status was significantly associated with the DR
locus (OR: 25.2 for each DR_3 allele, OR: 3.0 for each
DR_2 allele), gender (OR: 2.8 for females), and smoking
history (OR: 2.5 for previous smoker). The overall Cox &
Snell R2 for the model was 0.515, with a majority of the
influence coming exclusively from the DR locus (Cox &
Snell R2 = 0.493).
IgM was significantly associated with smoking and, to a
lesser extent, with gender, but not with the DR alleles.
Anti-CCP was only significantly associated with the DR_3
allele. Severity was not associated with any covariate. Age
at onset was significantly associated with the DR_3 allele,
smoking history, and female gender.
Genetic analyses
A genome screen of the qualitative phenotype (affected
versus unaffected) yielded a significant LOD score only for
the region on chromosome 6 harboring the DR locus.
QTL analysis of the quantitative traits yielded significant
LOD scores for a total of five chromosomal regions (see
Table 1). IgM and anti-CCP were transformed to reduce
the levels of kurtosis (from 33.4 to 0.6 and from -1.4 to
0.7, respectively).
PDT analysis of SNP data from each of the affected fami-
lies yielded significance on chromosome 6 near the DR
locus, as well as on chromosomes 11 (SNP11_387 and
SNP11_389; p = 10-6 and p = 6 × 10-16) and on chromo-
some 18 (SNP18_269; 5 × 10-6). A Bonferonni correction
for 8723 tests yields an alpha of 5 × 10-6. All other SNPs
had p-values below this threshold and were therefore not
significant.
Linear regression identified several SNPs that contributed
to the variation in the quantitative traits. Those SNPs were
then used to form haplotypes of varying sizes in an
attempt to characterize their influence. SNP11_389 alone
captured nearly 50% of the variance within the trans-
formed distribution of the IgM trait, after accounting for
the effects of gender and smoking, a result that did notBMC Proceedings 2007, 1(Suppl 1):S30 http://www.biomedcentral.com/1753-6561/1/S1/S30
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improve with a larger haplotype. This SNP was also a sig-
nificant predictor of affection status (p = 10-32).
The deleterious haplotype for the region on chromosome
18 was not obvious; however, the haplotypes resulting
from SNP18_268, SNP18_269, and SNP18_270 did the
best at predicting anti-CCP levels (p = 10-16). SNP18_269
by itself, however, was best at predicting affection status (p
= 2 × 10-8).
Determining the specific deleterious haplotype for the
region on chromosome 9 was not straightforward. The
best four SNPs appear to be SNP9_185, SNP9_186,
SNP9_189, and SNP9_190. When predicting severity, the
R2 value was fairly low (R2 = 0.040; p = 5 × 10-9) given the
size of this haplotype. The selected SNPs were not at all
associated with affection status (p = 0.391). Similarly, no
association with either severity or affection status could be
identified for any of the SNPs under the chromosome 8
linkage peak.
Prediction of phenotype
After adding in the newly identified deleterious SNPs
(SNP11_389 and SNP18_269) to the model described
above, the Cox & Snell R2  increased to 0.531 (The
Nagelkerke R2 increased from 0.683 to 0.705). The addi-
tion of these two factors improved the results from MDR
from a balanced testing accuracy of 85.7% to 86.5% (See
Table 2 for a summary). All individuals with two DR alle-
les were classified as affected by the final model. Those
with only one DR allele were classified based upon other
factors. No individuals without a DR allele were classified
as affected. Those 405 affected individuals who were mis-
classified as unaffected by the MDR algorithm were then
used in the second stage of the analysis.
Second-stage genetic analysis
Two loci, SNP6_154 (p = 5.2 × 10-9) and SNP6_162 (p =
1.6 × 10-6), exceeded a Bonferroni correction for 9187
tests (α = 5.6 × 10-6).
Discussion
Without prior knowledge of the underlying model, this
two-stage, classification strategy identified linkage to all
eight loci except for what was referred to as locus A and
identified significant association to all loci except for
locus A and B. When linkage disequilibrium (LD) was
assessed between these two underlying SNPs and the
SNPs nearest to them in the provided data set, it becomes
clear that the reason for the false negatives was the
Table 1: Genome screen results (LOD scores) for replicate 1
Chromosome [Location (cM)]
Trait (any covariates included) 6 (49 cM) 8 (169 cM) 9 (50 cM) 11 (115 cM) 18 (94 cM)
Affection status
Mapmaker/SIBS 50.4
AgeAtOnset (including gender)
Haseman-Elston 3.1 4.4
SOLAR 4.2 4.5
Severity
Haseman-Elston 8.6 9.6
SOLAR 9.0 7.5
Anti-CCP† (including gender)
Haseman-Elston 5.4 (1.8)
SOLAR 4.9† (2.2)
Anti-CCP† (including gender and DR alleles)
Haseman-Elston (1.0) 3.3
SOLAR (1.3) 3.8†
Anti-CCP transformed (including covariates)
Haseman-Elston (0.5) 5.1
SOLAR (1.2) 7.9
IgM†(including gender and smoking history)
Haseman-Elston (1.2)
SOLAR 4.9†
IgM transformed (including covariates)
Haseman-Elston 10.8
SOLAR 22.4
†Results from SOLAR for these untransformed variables should not be considered valid because these trait distributions had high levels of kurtosis 
and were the only ones to yield a lot of noise (additional findings on other chromosomes with LOD scores approaching and exceeding 3.0 that are 
assumed to be false positives).BMC Proceedings 2007, 1(Suppl 1):S30 http://www.biomedcentral.com/1753-6561/1/S1/S30
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absence of LD (r2 = 0.00). Those SNPs that could be iden-
tified were in LD with their nearest marker (See Figure 1).
The level of kurtosis in the IgM trait was an unacceptable
33.4, but transforming the trait distribution not only
brought the kurtosis (and therefore the false positive rate
in SOLAR) under control, but it increased its power to
detect linkage as well. Moreover, locus F on chromosome
11 could not be discerned from noise without this trans-
formation. While the kurtosis of anti-CCP started off at -
1.4, its power to detect linkage was also improved through
transformation.
Prediction accuracy improved from 86% at baseline to
89% after two rounds of genetic analyses. Upon receiving
the "answers" (a description of the underlying model),
the classification methods were rerun using the markers
directly surrounding the underlying causal loci and by
directly modelling the mode of inheritance for each locus.
This posterior information did not improve the prediction
accuracy (Table 2). When the underlying genotypes of the
susceptibility loci that were provided with the Answers
were analyzed, classification accuracy only improved to
90% (Table 2, Figure 2).
Conclusion
Incorporating information gained from linkage analysis
and candidate gene association studies can create a sub-
sample that is enriched for previously unidentified genes
and thereby improves power to detect these additional
loci in a whole-genome association analysis. Two loci (C
and D) that were previously "over shadowed" by the DR
locus were identified by factoring out information gained
in the first round of analyses. While this study used link-
age and candidate gene information, the source of prior
information could also have come from another source,
such as a previous whole-genome association (particu-
larly one using a different type of sample, for instance
cases and controls instead of trios). Similarly, other classi-
fication methods could be use instead of regression or
MDR.
For these data, MDR did not outperform logistic regres-
sion. This is most likely due to the underlying simulation
parameters. Since the only gene × gene or gene × environ-
ment interactions modelled were impossible to detect (r2
= 0.0 for all markers surrounding Locus A and Locus B),
there were no high order interactions for MDR to identify
– the software's raison d'etre. Similarly, the simulation
parameters assumed the common disease, common gene
hypothesis in which the same high-risk allele either arose
several times independently or arose so long ago that the
background haplotype was almost completely degraded.
Both situations would mean that haplotype methods, par-
ticularly for the marker density provided, could not pro-
vide more information than the analysis of single SNPs
independently.
An additional consequence of the underlying simulation
parameters resulted from its design to mimic an existing
rheumatoid arthritis data set, which appears to contain a
DRB1 allele with a large effect. In the simulated data set,
this large effect realistically masked the signal of two
smaller genes that were rendered undetectable if the effect
of the larger gene was not taken into account. The two-
stage classification approach used in this paper is one way
to address this issue. A strategy such as this may prove to
be equally successful in a real data set.
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Table 2: Classification results
Logistic regression
MDR testing accuracy Maximized accuracy Nagelkerke R2 Factors
Before undertaking genetic analyses
82.6% 84.3% 0.652 Number of DR 3 alleles
85.7% 85.7% 0.683 Number of DR 3 alleles, sex, smoked
Using results from first round of genetic analyses
86.5% 86.4% 0.705 Number of DR 3 alleles, sex, smoked, SNP11_389, SNP18_269
Using results from second round of genetic analyses
88.4% 88.5% 0.715 Number of DR 3 alleles, sex, SNP6_154, SNP6_162
88.2% 88.5% 0.746 +Smoked, SNP11_389, SNP18_269
Using SNPs/SNP haplotypes nearest the underlying loci as described in the "answers"
88.5% 88.5% 0.746 The SNPs nearest loci A-F, sex, smoking, DR genotype
Using the underlying loci provided in the "answers"
88.7% 90.1% 0.773 Number of deleterious alleles at loci A-F, sex, smoking, DRBMC Proceedings 2007, 1(Suppl 1):S30 http://www.biomedcentral.com/1753-6561/1/S1/S30
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LD between underlying loci and surrounding SNPs Figure 1
LD between underlying loci and surrounding SNPs. The moderate to strong LD between locus E, locus F, and their 
respective nearest markers explains why these loci were easy to detect. Similarly, the lack of LD (r2 = 0.0) between locus A, 
locus B, and their respective nearby markers explains why association with these loci could not be detected.Publish with BioMed Central    and   every 
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